The Digipath Certified Seal – A Mark of Confidence
The Company offers comprehensive medical cannabis safety screening and an independent certification system, including the “Digipath Labs Certified” certification seal. This seal is identified by labels and stickers provided to participating dispensaries and growers so they may better self-regulate their processes in order to assure safe and clean medicines and to advance the cause of cannabis therapeutics. Independent testing reduces the risks of contamination and thereby improves the overall quality of the cannabis distributed as medicine through the dispensaries.
Digipath’s certification program helps medical cannabis patients know the quality of the cannabis they are using as medicine. The Digipath Certified Seal assures the patient that their products are pure, pesticide-free, and properly measured for potency. With the Digipath Certified Seal and certification program, growers can ensure quality and improve their operations. Advocates, patients, dispensaries, and growers all benefit from testing that helps to legitimize medical cannabis. Rather than suffering a quality crisis that fuels the opposition, the medical cannabis industry can thrive in an atmosphere of self-regulation and control as testing confirms that the medicines are safe and effective.
Comprehensive Cannabis Testing for Greatest Quality Assurance and Consumer Safety
Digipath Labs screens medicinal cannabis and cannabis-based products for both potency and quality for potentially harmful contaminants, including:
Digipath Labs also tests cannabis and cannabis-based products for potency by analyzing the chemoprofiles, including both cannabinoid and terpenoid profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.
Digipath’s Intellectual Property Enables True, Standardized Definition and Identification of Strains
Currently, the lack of standardized naming conventions in the cannabis industry (use of acronyms, non-standard abbreviations, etc.) is making it increasingly difficult to know what is on the market and to make effective comparisons. This uncertainty is impacting many ancillary efforts, including confidence at the dispensary, and is creating a regulatory quagmire for trademarking and patenting strains (i.e. cultivars).
•Residual solvents (for non-CO2 extracts)
•Pesticides
•Heavy metals (e.g. mercury, arsenic, lead, and cadmium)
•Biological toxins (e.g. mycotoxins: aflatoxins and ocratoxin A)
•Microbial contaminants including:
-pathogenic E. coli and Salmonella spp.
-Total Yeast & Mold (TYM)
-Total Aerobic Count (TAC)
-Enterobacteriaceae
-Coliforms
15